Luc van Lonkhuijzen
Overview
Explore the profile of Luc van Lonkhuijzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rauh-Hain J, Melamed A, Pareja R, May T, Sinno A, McNally L, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2446325.
PMID: 39570589
Importance: Despite the absence of high-quality evidence of its safety and effectiveness, minimally invasive surgery (MIS) is increasingly used to treat advanced epithelial ovarian cancer (EOC). Objective: To assess the...
2.
Kocian R, Kohler C, Bajsova S, Jarkovsky J, Zapardiel I, Di Martino G, et al.
Gynecol Oncol
. 2024 Jun;
188:83-89.
PMID: 38941963
Objective: To report the outcome of SLN staging in the SENTIX international prospective trial of SLN biopsy in patients with cervical cancer with an intensive ultrastaging protocol and central quality...
3.
Laan J, van Lonkhuijzen L, Hinnen K, Pieters B, Dekker I, Stalpers L, et al.
Int J Gynecol Cancer
. 2024 Jan;
34(4):497-503.
PMID: 38233092
Objective: Cancer patients are at risk of malnutrition, which is associated with poor oncological outcomes. The aim of this study was to assess the incidence of malnutrition before, during, and...
4.
Bronsema I, van Lonkhuijzen L, Scholten P, Laan J, Westerveld H, Stalpers L
Tech Innov Patient Support Radiat Oncol
. 2024 Jan;
29:100225.
PMID: 38173986
Objective: Continuation of smoking after a cancer diagnosis increases the burdensome side effects from cancer treatment, and decreases the chances of cure. Smoking cessation may improve oncological outcomes in cancer...
5.
Cibula D, Akilli H, Jarkovsky J, van Lonkhuijzen L, Scambia G, Meydanli M, et al.
Gynecol Oncol
. 2023 Jan;
170:195-202.
PMID: 36706646
Objective: The "intermediate-risk" (IR) group of early-stage cervical cancer patients is characterized by negative pelvic lymph nodes and a combination of tumor-related prognostic risk factors such as tumor size ≥2...
6.
Roze J, Sendino Garvi E, Stelloo E, Stangl C, Sereno F, Duran K, et al.
Cancers (Basel)
. 2021 Jan;
13(3).
PMID: 33498451
Adult granulosa cell tumors (AGCTs) arise from the estrogen-producing granulosa cells. Treatment of recurrence remains a clinical challenge, as systemic anti-hormonal treatment or chemotherapy is only effective in selected patients....
7.
Cibula D, Kocian R, Plaikner A, Jarkovsky J, Klat J, Zapardiel I, et al.
Eur J Cancer
. 2020 Aug;
137:69-80.
PMID: 32750501
Background: SENTIX (ENGOT-CX2/CEEGOG-CX1) is an international, multicentre, prospective observational trial evaluating sentinel lymph node (SLN) biopsy without pelvic lymph node dissection in patients with early-stage cervical cancer. We report the...
8.
Roze J, Monroe G, Kutzera J, Groeneweg J, Stelloo E, Paijens S, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32455687
Adult granulosa cell tumors (AGCTs) harbor a somatic c.402C>G mutation in ~95% of cases and are mainly surgically removed due to limited systemic treatment effect. In this study, potentially targetable...
9.
Nemejcova K, Kocian R, Kohler C, Jarkovsky J, Klat J, Berjon A, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32365651
The quality of pathological assessment is crucial for the safety of patients with cervical cancer if pelvic lymph node dissection is to be replaced by sentinel lymph node (SLN) biopsy....
10.
van der Velden J, Mom C, van Lonkhuijzen L, Tjiong M, Westerveld H, Fons G
Int J Gynecol Cancer
. 2019 May;
29(5):874-878.
PMID: 31133601
Background: The efficacy of adjuvant radiotherapy in patients with intermediate risk early cervical cancer after radical hysterectomy is still under debate. Most guidelines recommend adjuvant radiotherapy, whereas others consider observation...